So called cardiac-specific serum muscle damage markers [cardiac troponin T (cTnT) and cardiac troponin I (cTnI)] may have a role, but can lack specificity for cardiac disease in IIM, especially the cTnT, which is often elevated in those with skeletal muscle disease without cardiac involvement [5, 6]. Here, TNNI3 is linked to heart disorder.